Change search criteria ↓

Search results

10 projects found matching your search criteria:

  1. 1. Protein targeting to degradation: a new role of ABI1 protein phosphatase 2C in ethylene biosynthesis

    Principal investigator: dr Agnieszka Ludwików

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: OPUS 8, Panel: NZ3

  2. 2. Human exosomes as natural carriers of protein kinase CK2 inhibitors and degraders in targeted anticancer therapy.

    Principal investigator: dr hab. Patrycja Joanna Wińska

    Politechnika Warszawska

    Call: OPUS 28 (LAP), Panel: NZ5

  3. 3. The mechanisms of protein targeting to the endoplasmic reticulum channels during ER-associated degradation (ERAD)

    Principal investigator: dr hab. Monika Agnieszka Słomińska-Wojewódzka

    Uniwersytet Gdański, Wydział Biologii

    Call: OPUS 10, Panel: NZ3

  4. 4. PROteolysis TArgeting Chimeras (PROTACs) intended to knock down excessive amyloidogenic proteins, human islet amyloid po…

    Principal investigator: dr hab. Elżbieta Jankowska

    Uniwersytet Gdański, Wydział Chemii

    Call: OPUS 26, Panel: NZ7

  5. 5. Targeted Degradation of the MLL Complex in Leukemia: A PROTAC-Based Therapeutic Strategy

    Principal investigator: dr Natalia Anna Skrzypczak

    Fundacja Uniwersytetu im. Adama Mickiewicza

    Call: SONATINA 9, Panel: ST5

  6. 6. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c…

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ7

  7. 7. Targeted degradation of Rab geranylgeranyl transferase as a new approach to investigate prenylation of Rab GTPases

    Principal investigator: dr hab. Edyta Violetta Gendaszewska-Darmach

    Politechnika Łódzka, Wydział Biotechnologii i Nauk o Żywności

    Call: PRELUDIUM BIS 2, Panel: NZ1

  8. 8. A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven dis…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 24 (LAP), Panel: NZ7

  9. 9. Canonical and non-canonical roles of DDK in oncogenesis: a cornerstone for the development of novel, potent anticancer t…

    Principal investigator: dr Jan Marian Suski

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 14, Panel: NZ3

  10. 10. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces…

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

    Call: OPUS 27, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski